Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023)
Avalo Therapeutics' (AVTX) quarterly Change in Inventory came in at -$18000.0 in Q3 2023, down 1700.0% YoY from $1125.0 in Q3 2022, and down 1700.0% on a QoQ basis from -$1000.0 in Q2 2023.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023) Analysis & Trends
Avalo Therapeutics (AVTX) has 7 years of Change in Inventory data on file, last reported at -$18000.0 in Q3 2023.
- Quarterly Change in Inventory fell 1700.0% year-over-year to -$18000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$18000.0 (down 260.0% YoY) and the FY2023 annual result came in at -$20000.0, down 11.11% from the prior year.
- Change in Inventory declined to -$18000.0 in Q3 2023, from -$1000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $68294.0 in Q4 2019 to a low of -$411736.0 in Q2 2019.
- A 5-year average of -$29155.1 and a median of -$3000.0 in 2020 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory surged 600.0% — and 2023, when it sank 1700.0%.
- Tracing AVTX's Change in Inventory over 5 years: stood at $68294.0 in 2019, then plunged by 108.79% to -$6000.0 in 2020, then surged by 466.67% to $22000.0 in 2021, then plunged by 109.09% to -$2000.0 in 2022, then sank by 800.0% to -$18000.0 in 2023.
- The last three Change in Inventory figures came in at -$18000.0 (Q3 2023), -$1000.0 (Q2 2023), and -$1000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Avalo Therapeutics | 843.26 Mn | 843.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -6,000.00 |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | -4,000.00 |
| Mar 31, 2020 | -5,000.00 |
| Dec 31, 2019 | 68,294.00 |
| Sep 30, 2019 | -148,310.00 |
| Jun 30, 2019 | -411,736.00 |
| Mar 31, 2019 | -41,195.00 |
| Dec 31, 2018 | 84,464.00 |